Jonas Löfling

609 citations
11 papers · 485 indexed · h-index 11

Impact in

Papers in

Jonas Löfling

11 papers receiving 478 citations

Peers

Jonas Löfling
Comparison fields: 5 of 61
  • Endocrinology 86
  • Microbiology 49
  • Infectious Diseases 80
  • Immunology 88
  • Molecular Biology 264
Replace Susan R. Heimer with:
Susan R. Heimer United States
Allison J. Farrand United States
Marco Biancucci United States
Dragana Nešić United States
Jessica Poole Australia
Gabriella Garufi United States
Naoto Yoshino Japan
Seán Hanniffy Spain
Simon Devos Belgium
Justine Younson United Kingdom
Jonas Löfling relative to Susan R. Heimer United States Susan R. Heimer's profile →
Citations per field
00.5×1.5×
Susan R. Heimer · 1×
Citations per year

Countries citing papers authored by Jonas Löfling

Since Specialization
Citations

This map shows the geographic impact of Jonas Löfling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Löfling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Löfling more than expected).

Fields of papers citing papers by Jonas Löfling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Löfling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Löfling. The network helps show where Jonas Löfling may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jonas Löfling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonas Löfling Line = papers co-authored together Jonas Löfling links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 201623
2 201642
3 201424
4 201332
5 201046
6 200932
7 200824
8 200815
9 2008182
10 200647
11 200218

About Jonas Löfling

Jonas Löfling is a scholar working on Endocrinology, Microbiology, Immunology and Allergy, Biotechnology and Molecular Biology, having authored 11 papers that have together received 485 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (7 papers), Escherichia coli research studies (3 papers), Pneumonia and Respiratory Infections (2 papers), Streptococcal Infections and Treatments (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Bacterial Infections and Vaccines (2 papers), Virus-based gene therapy research (1 paper) and Respiratory viral infections research (1 paper). The work is most often cited by research in Endocrinology (86 citations), Microbiology (49 citations), Infectious Diseases (80 citations), Immunology (88 citations) and Molecular Biology (264 citations). Jonas Löfling has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Jan Holgersson, Ajit Varki, Birgitta Henriques‐Normark, Adrienne W. Paton, Nissi Varki, James C. Paton, Travis Beddoe, Matthew C. J. Wilce, Emma Byres and Ursula M. Talbot. Their work appears in journals such as Glycobiology, Scientific Reports, Kidney International, Cell Host & Microbe and Cellular Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026